info [at] nonfiction.design
55 Grace Street, San Francisco, California
Endiatx develops micro-robots that have the potential to replace in-hospital endoscopies. They are swallowed by the patient and controlled remotely by a doctor who can visually examine the inside of the upper gastrointestinal tract in real time. This technology eliminates months of waiting and uncomfortable procedures and helps diagnose life-threatening conditions early. Pillbot™ is inspired by Interspace, a 1987 sci-fi movie with a miniaturized craft that travels through the body.
In hospitals today, you can access electronic pills with cameras controlled by magnets using massive, stationary, and costly MRI machines. The Endiatx difference lies in the fact that biomechanical and aerospace engineers collaborated to develop a pill that a doctor can control remotely. This revolutionary way of thinking has the potential to open access and accessibility to telemedicine and urgent care to people who otherwise wouldn’t have access to it. The long-term vision for Endiatx is to miniaturize Pillbot and reduce its cost so it can be accessible to everyone from the comfort of their homes. A technology like Pillbot can be a game changer for people living hours away from the doctor or hospital. It saves numerous lives from preventable conditions.
In the process of fundraising for the development of Pillbot, the leadership at Endiatx reached out to Nonfiction to help them tell a compelling story of how and why Pillbot is a venture worth investing in. After interviewing founder Torrey Smith, it became evident that his drive for turning science fiction into reality had a deeply personal origin story. He also thought far into the future on the potential of Pillbot and how other Endiatx products might revolutionize access to care.
Nonfiction took that information, wrote a compelling script, and produced a short format video that tells an origin story able to touch people’s hearts even if the audience has no experience with gastrointestinal issues. One of the common problems working with new technologies is that it’s common for startups to need clarification on the messaging because they are solely focused on science (What) and technology (How). As a design firm, Nonfiction aims to direct the messaging toward the Who and the Why.
Thanks to powerful storytelling and editing, the Endiatx origin story and 60-second video was able to garner $1.5+ million within weeks of launching the video. Its release facilitated engagement with medical partners captured the attention of the TED Global Conference and even talked Adam Savage of Mythbusters into swallowing not one but two Pillbots. And if you’re wondering what happens to Pillbot once it has done its job, it is naturally passed through the patient’s gastrointestinal tract without being digested.
Endiatx develops micro-robots that have the potential to replace in-hospital endoscopies. They are swallowed by the patient and controlled remotely by a doctor who can visually examine the inside of the upper gastrointestinal tract in real time. This technology eliminates months of waiting and uncomfortable procedures and helps diagnose life-threatening conditions early. Pillbot™ is inspired by Interspace, a 1987 sci-fi movie with a miniaturized craft that travels through the body.
In hospitals today, you can access electronic pills with cameras controlled by magnets using massive, stationary, and costly MRI machines. The Endiatx difference lies in the fact that biomechanical and aerospace engineers collaborated to develop a pill that a doctor can control remotely. This revolutionary way of thinking has the potential to open access and accessibility to telemedicine and urgent care to people who otherwise wouldn’t have access to it. The long-term vision for Endiatx is to miniaturize Pillbot and reduce its cost so it can be accessible to everyone from the comfort of their homes. A technology like Pillbot can be a game changer for people living hours away from the doctor or hospital. It saves numerous lives from preventable conditions.
In the process of fundraising for the development of Pillbot, the leadership at Endiatx reached out to Nonfiction to help them tell a compelling story of how and why Pillbot is a venture worth investing in. After interviewing founder Torrey Smith, it became evident that his drive for turning science fiction into reality had a deeply personal origin story. He also thought far into the future on the potential of Pillbot and how other Endiatx products might revolutionize access to care.
Nonfiction took that information, wrote a compelling script, and produced a short format video that tells an origin story able to touch people’s hearts even if the audience has no experience with gastrointestinal issues. One of the common problems working with new technologies is that it’s common for startups to need clarification on the messaging because they are solely focused on science (What) and technology (How). As a design firm, Nonfiction aims to direct the messaging toward the Who and the Why.
Thanks to powerful storytelling and editing, the Endiatx origin story and 60-second video was able to garner $1.5+ million within weeks of launching the video. Its release facilitated engagement with medical partners captured the attention of the TED Global Conference and even talked Adam Savage of Mythbusters into swallowing not one but two Pillbots. And if you’re wondering what happens to Pillbot once it has done its job, it is naturally passed through the patient’s gastrointestinal tract without being digested.
